Filter
1684
Filtered Results: 1684
Text search:
drug
financing
Featured
Recommendations
109
New Publications
563
Language
Document type
No document type
1083
Studies & Reports
282
Guidelines
114
Strategic & Response Plan
97
Manuals
46
Situation Updates
35
Fact sheets
14
Training Material
7
Infographics
5
Resource Platforms
1
Countries / Regions
Global
84
Kenya
74
Uganda
55
Sierra Leone
50
Nigeria
47
Ethiopia
46
Western and Central Europe
45
Liberia
44
India
40
Malawi
39
Nepal
38
Zambia
37
Ghana
35
South Africa
32
Africa
30
Myanmar / Burma
30
Tanzania
28
Bangladesh
28
Rwanda
27
Eastern Europe
27
Asia
24
Cambodia
22
Ukraine
20
Namibia
20
Latin America and the Carribbean
19
Philippines
18
Lesotho
15
South–East Asia Region
15
Botswana
15
Zimbabwe
12
Senegal
11
Indonesia
11
Mozambique
10
Congo, Democratic Republic of
8
Burkina Faso
7
Guinea
7
Haiti
7
East and Southern Africa
7
Russia
7
Eswatini/ Swaziland
7
Cameroon
6
Pakistan
6
Albania
5
Middle East and North Africa
5
Eastern Europe and Central Asia
5
Georgia
5
Tajikistan
4
Thailand
4
Syria
4
Laos
4
Venezuela
4
Germany
4
West and Central Africa
4
Western Pacific Region
4
Vietnam
4
Moldova
4
Benin
3
Afghanistan
3
Armenia
3
Paraguay
3
Sudan
3
South Sudan
3
North Macedonia
2
China
2
Jordan
2
North America
2
Jamaica
2
Sri Lanka
2
Central African Republic
2
Colombia
1
Timor Leste/ East Timor
1
Turkey
1
Gambia
1
Kazakhstan
1
Kyrgyzstan
1
Uzbekistan
1
Peru
1
Mongolia
1
Qatar
1
Bulgaria
1
USA
1
Belgium
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Papua New Guinea
1
Brazil
1
Honduras
1
Libya
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
791
Public Health
106
Clinical Guidelines
73
Women & Child Health
49
Key Resources
44
Pharmacy & Technologies
12
Capacity Building
7
Toolboxes
TB
213
HIV
201
Mental Health
86
AMR
72
COVID-19
53
Health Financing Toolbox
45
Pharmacy
43
NTDs
36
Global Health Education
30
NCDs
29
Planetary Health
26
Caregiver
23
Ebola & Marburg
20
Rapid Response
15
Disability
15
Conflict
14
Refugee
12
Polio
11
Malaria
5
Natural Hazards
4
Social Ethics
3
Zika
2
Cholera
1
The world has been turned on its head by the coronavirus disease 2019 (COVID-19) pandemic. This has provided a stark wakeup call on the severe under-financing of health systems around the world. It has laid bare the inequalities and limitations in the capacities of countries at all levels of develop...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Financing Global Health 2013: Transition in an Age of Austerity, IHME’s fifth annual report on global health expenditure, depicts financing trends that underline the resilience of development assistance for health. This year’s updated estimates show that despite lackluster economic growth and fi...
The GFF needs an additional US$2.5 billion from 2021 to 2025 to enable countries to protect health gains and accelerate progress toward the 2030 Goals. Of this amount, the GFF urgently needs to secure new pledges of US$1.2 billion by the end of 2021 to help its current 36 partner countries protect ...
The COVID-19 pandemic demonstrated that
the world was not well prepared to respond
to an infectious disease threat of this magnitude. Countries across all socioeconomic and development categories have struggled
to implement effective national responses. Substantial amounts of additional investmen...
Agodokpessi et al. Journal of Pharmaceutical Policy and Practice (2015) 8:12DOI 10.1186/s40545-015-0033-7
Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated
the operation of the RDF and assessed whether there was interruption of supply of asthma me...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
Financing Global Health 2015 is the seventh edition of IHME’s annual series on global health financing. This report captures trends in development assistance for health (DAH) and government health expenditure as source (GHE-S) in low- and middle-income countries. Annually updated GHE-S and DAH est...
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
World Drug Report 2017
-5-
Accessed: 14.03.2019
Strategic Overview
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, development assistance for health (DAH) has grown at an annualized rate of 1.0%. While global development ass...
